Muhammad Tahseen
Overview
Explore the profile of Muhammad Tahseen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Asghar K, Loya A, Rana I, Tahseen M, Ishaq M, Farooq A, et al.
Cancer Manag Res
. 2019 Jan;
11:475-481.
PMID: 30655699
Background: Immune dysfunction in breast cancer patients is well established. Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme that is linked with progression of cancer. IDO is overexpressed in triple-negative breast...
12.
Rashid M, Muhammad N, Bajwa S, Faisal S, Tahseen M, Lorenzo Bermejo J, et al.
BMC Cancer
. 2016 Aug;
16(1):673.
PMID: 27553291
Background: Women harboring BRCA1/2 germline mutations have high lifetime risk of developing breast/ovarian cancer. The recommendation to pursue BRCA1/2 testing is based on patient's family history of breast/ovarian cancer, age...
13.
Saleem S, Jamshed A, Faisal S, Hussain R, Tahseen M, Loya A, et al.
Cancer Cell Int
. 2015 Feb;
14(1):542.
PMID: 25685059
Recently a sub-population of cells with stem cell characteristics, reported to be associated with initiation, growth, spread and recurrence, has been identified in several solid tumors including oral tongue squamous...
14.
Bukhari M, Niazi S, Khaleel M, Sharif M, Ghani R, Mehmood M, et al.
J Cutan Pathol
. 2008 Aug;
36(2):220-8.
PMID: 18715257
Background: Epidermal squamous cell carcinoma (SCC) isa common malignancy in Pakistan. We hypothesize that it is characterized by higher frequency of p53 genetic mutations and increased AgNOR values compared with...